Trial of New Alzheimer’s Drug Reports Disappointing Results

2 weken geleden

New York Times

The drug, crenezumab, failed to prevent early symptoms or slow cognitive decline, the latest setback in the long quest to find effective therapies for the disease.

Klik voor bronartikel

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Ook interessant voor je

onderzoek

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Almost all children involved with copies of the SMN2 gene treated pre-symptomatically met key milestones

PMLiVE

5 x gelezen

onderzoek

What’s next for the synthetic lethality drug discovery engine?

Nature Reviews Drug Discovery, Published online: 16 June 2022; doi:10.1038/d41573-022-00107-0 As a surge of drugs with new synthetic lethality targets enter the clinic, the opportunities and challenges of the underlying...

Nature Reviews Drug Discovery

5 x gelezen

onderzoek

Sanofi and GSK share positive data for two COVID-19 booster vaccine trials

Sanofi and GSK have jointly developed a next-generation COVID-19 booster vaccine candidate, based on Sanofi’s recombinant Beta variant antigen and combined with GSK’s pandemic adjuvant. Both have served as established...

PMLiVE

3 x gelezen